Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,060 | -19,540 | -20,620 | -10,050 | -23,210 |
| Depreciation Amortization | 2,870 | 440 | 770 | 360 | 1,590 |
| Other Working Capital | 4,200 | 4,990 | 8,600 | 9,110 | -7,680 |
| Other Operating Activity | -6,250 | -3,460 | 4,070 | 1,390 | -1,820 |
| Operating Cash Flow | $-26,240 | $-17,570 | $-7,180 | $810 | $-31,120 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -710 | -690 | -670 | -210 | -50 |
| Other Investing Activity | 3,170 | 3,170 | 0 | 0 | 0 |
| Investing Cash Flow | $2,460 | $2,480 | $-670 | $-210 | $-50 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 38,550 | 30,600 | 21,400 | 5,080 | 25,430 |
| Financing Cash Flow | $38,550 | $30,600 | $21,400 | $5,080 | $25,430 |
| Exchange Rate Effect | 100 | 600 | 1,070 | 630 | -360 |
| Beginning Cash Position | 31,990 | 31,990 | 31,990 | 31,990 | 38,100 |
| End Cash Position | 46,880 | 48,110 | 46,610 | 38,310 | 31,990 |
| Net Cash Flow | $14,880 | $16,110 | $14,610 | $6,310 | $-6,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,240 | -17,570 | -7,180 | 810 | -31,120 |
| Free Cash Flow | -26,240 | -17,570 | -7,180 | 810 | -31,120 |